Roles of activator protein-2 gamma in breast cancer: A narrative review (SANRA).

Yifei Zhang, Asal Aa Mostafa, Natthida Sriboonvorakul, Jiamiao Hu

Journal: Medicine 2022;101(38):e30587

PMID: 36197225

Abstract

Activator protein-2 gamma (AP-2γ) is a crucial transcription factor involved in breast cancer development. Abnormal expression and activity of AP-2γ have also been identified as important markers of malignancy. In the last decade, the importance of AP-2γ in breast cancer progression has been widely studied. In this review, we summarize the current knowledge on the regulatory roles of AP-2γ in breast cancer oncogenesis and progression and its potential as a diagnostic biomarker and drug target in breast cancer treatment.

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Address: Engineering Research Centre of Fujian-Taiwan Special Marine Food Processing and Nutrition, Ministry of Education, Fuzhou, Fujian, China.; Food Technology Research Institute, Agriculture Research Center, Egypt.; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Faculty of Health Sciences, University of Macau, Macau, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.